Alopecia Areata Trial, Recruiting NCT07107841 Sponsor: Acorn Biolabs Inc. Condition: Alopecia Areata
Back to Alopecia Areata

Alopecia Areata Trial, Recruiting

NCT07107841
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old (male or female).
  • You have been diagnosed with androgenic alopecia (common pattern hair loss/baldness).
  • If you are male and currently taking minoxidil (oral or topical) and/or a 5-alpha reductase inhibitor (a type of hair loss medication), you have been on the same dose and type for at least 12 months and plan to keep it stable throughout the study.
  • If you are female, you have not used any hair growth medications or topical hair treatments for at least 6 months before the study starts.
  • If you use testosterone replacement therapy (in any form, such as injections, patches, gels, or pellets), you have been on a stable course of it for at least 12 months.
  • You are not planning to start any new hair growth treatments or change your current hair loss medication during the study.
  • You are willing and able to attend all scheduled clinic visits for the study.
  • You are comfortable receiving multiple injections of the study product into the scalp.
  • You are willing to keep the same hairstyle throughout the entire study period.
  • You agree to have up to 5 tiny dot tattoos (about the size of a pencil tip) placed on your scalp — either UV (invisible under normal light, only visible under black light) or red colored — and agree to touch-ups if needed.
  • You are able to understand the study and are willing to sign a consent form agreeing to take part.

Who may not be able to join:

  • You have alopecia areata or another type of hair loss that is not androgenic (pattern) hair loss.
  • You have an active scalp skin condition, such as psoriasis or severe dandruff (seborrheic dermatitis).
  • You currently have a scalp infection.
  • You have a severe active infection anywhere in your body.
  • You have cuts or open sores on your scalp.
  • You have had a surgical hair restoration procedure (such as a hair transplant) in the last 12 months.
  • You have had cancer in the last 5 years (except for certain common skin cancers — basal cell or squamous cell carcinoma).
  • You have a history of chemotherapy or radiation treatment.
  • You have a history of thyroid problems.
  • You have a history of certain autoimmune conditions, specifically Graves' disease, Hashimoto's thyroiditis, or lupus (SLE).
  • You regularly take anti-inflammatory medications (such as ibuprofen or aspirin) or Vitamin E daily, unless you stop taking them at least 7 days before your first treatment and only use them occasionally during the study.
  • You have taken any medications known to cause hair loss (such as certain steroids or specific other drugs) within the last 3 months (confirm with trial site for the full list).
  • You have a known allergy or sensitivity to tattoo ink.
  • You are currently taking blood-thinning medications (such as warfarin, heparin, or similar drugs).
  • You have a strong tendency to develop raised or thick scars (keloids or hypertrophic scarring).
  • You are unable to communicate with the research team.
  • You have any other health condition that the study doctor feels would make it unsafe for you to participate (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisa M Campbell, PhD, Acorn Biolabs

Phone: 905-695-6956

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Acorn Biolabs Inc.
Registry
ClinicalTrials.gov
Start date
16 October 2025
Est. completion
15 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Target Area Hair Counts (TAHC); Safety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov